case_images: PMC10874154_01
case_images: Disseminated distribution of erythematous plaques on lower and upper extremities prior to initiating treatment with adalimumab.
case_images: 10.1177_2050313X241231427-fig1.jpg
case_images: PMC10874154_01_10.1177_2050313X241231427-fig1.jpg
case_images: fig1-2050313X241231427
case_images: Upon examination, the patient had erythematous annular plaques distributed to her upper and lower extremities and trunk (Figure 1).
case_images: Mild post-inflammatory maculated hyperpigmented residuum after 18 months of treatment with adalimumab.
case_images: 10.1177_2050313X241231427-fig2.jpg
case_images: PMC10874154_01_10.1177_2050313X241231427-fig2.jpg
case_images: fig2-2050313X241231427
case_images: She also had no new active lesions and only mild post-inflammatory hyperpigmentation (Figure 2).